Creative Details

Quality Score: 6/10

The advertisement promotes Repatha (evolocumab) and highlights the personalized support available through Amgen SupportPlus, emphasizing that the medication is covered by health insurance for 9 out of 10 patients.

Creative Information

CID:1127ca03-c719-49ad-a91f-0549202989a6
CRID:25_kfs9ovnb
Domain:repathahcp.com
Seat:TTD
Size:300x600
Bid:$0.27
Timestamp:11/7/2025, 5:19:47 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/19/2025, 2:00:43 AM6.38s
    adomain_analysissuccess11/19/2025, 3:05:52 AM3.31s
    adomain_capturesuccess11/19/2025, 3:05:48 AM0.19s
    ad_rendersuccess11/19/2025, 2:00:37 AM39.90s
    brand_mappingsuccess11/18/2025, 9:58:12 PM0.14s

    Analysis Results

    Ad Format: banner

    Brands: Repatha

    Sensitive:Pharmaceutical Products
    Quality:Adomain not match landing page domain
    Size:300x600
    Data Transferred:1955.01 KB
    Render Time:8.13 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Personal Finance (IAB13)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Landing Page:
    https://www.repathaespanol.com/sign-up?dclid=CP_26...
    Domain:www.repathaespanol.com
    Brand:
    Repatha
    Total Ad Size:1974.23 KB
    Requests Made:
    URLSize (KB)
    https://cdn.doubleverify.com/dvbm.js529.10
    https://s0.2mdn.net/sadbundle/6795752907673833826/300x600_24_tha_fp_2045_AS_Program/300x600.js438.34
    https://s0.2mdn.net/ads/studio/cached_libs/createjs_2019.11.15_min.js236.38
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js222.95
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N2525149.3848558MATTERKIND/B33178340.415330570;dc_ver=106.314;dc_eid=40004000;sz=300x600;u_sd=1;gdpr=0;nel=1;dc_adk=2027040026;ord=2firq7;click=https%3A%2F%2Finsight.adsrvr.org%2Ftrack%2Fclk%3Fimp%3D05a21b16-77a7-410f-b460-35d6ef9997dd%26ag%3Dd0e2ihe%26sfe%3D1b4ca1e9%26sig%3Dc6dxlWXYjNo7OVzTRNlMlQwCHJD7UIrodM0mqQ3b5BI.%26crid%3Dkfs9ovnb%26cf%3D8926889%26fq%3D0%26t%3D1%26td_s%3Dmail.aol.com%26rcats%3Doj8%26mste%3Dmail.aol.com%26mfld%3D2%26mssi%3D%26mfsi%3D%26sv%3Dkargo%26uhow%3D91%26agsa%3D%26wp%3D0.39323875%26rgz%3D02067%26dt%3DPC%26osf%3DWindows%26os%3DWindows10%26br%3DChrome%26svpid%3D8727%26rlangs%3Den%26mlang%3D%26did%3D%26rcxt%3DOther%26tmpc%3D4.300000000000011%26vrtd%3D%26osi%3D%26osv%3D%26daid%3D%26dnr%3D0%26vpb%3D%26crrelr%3D%26npt%3D%26cc%3D2~KLUv_WMdqREMkgOtFgBz4Xi3XFtUbk1Uji0qx0VKAZcblkcXzFxUyrH3tpAwaLIpUkKElIovziJUrrq3IlTQEqCFSGABCwKNKCl0hKoBxaFlaEusQJP3GKPCHhxg6gw5JOeLmySvBX494WzxJ441bekvzEpGd-HEMZ6rLAPOfVTnaqHQvOYC97EeDRs2tmsSw8C6eiQWWjujWLDsLooGxtXnJPGoNBsbzvNSv471vqS6bBPzZl5WVV65rF1cyTmqO2vmsofm_6RMXml2S8OAyyDajgoF_pD9TwwfZnu6kFmHzduyYLEmxra_s-ksN8_-MFArHVJ123xbXSJ151TKgz2JXj1j8qfCZzJSzOZF-WRRyn_lPvFXNguB-FPs_-JSnWN_PEST0cq-oELe5__uJk9mKrnR2io8Q5OVYs94_8W4fGREsRvJ0xXvXtoz6zF51zVPq9S-V3_telLf0b4-xZJItFo3VsbbwVaEJgTZIsThhJwLJQQwVjny8y3PfKzb5VrX_Xgs6Ea15q77uoZv3MfxvO_pOTsGVWLxzm6URMG1_VK7j6mwGRZBZXycuG1YToCf8R3Odd_vdbvM97rdl_3bh-kXamyk7VBsNK92HzXxYnAEUVfoK5fyHx8_IuGp07C8OwhZJgmOCDCh5nOa1-n71wpG_MCUQc5LpmNBrJx4tUMIgUMwIpSy9woJh7EzDQpmd6TUYV8BuoJJEYofWstS_Ra4ZcWmFuENqVHLZ39E4Pv9JytGo_s6wNNUIHbbYM8DWGTz8jQjc0Y3kGz36HN4DTZW3Yxem_r-ehEA_eCyIMI2S5p8TFnsZFqhMJPvHtEViCaviI8rfY8j_4QfxF4BOV4pMima0j5Dijc5G2SUeW4sPgHoU2W6elOoF_Kfhhup3DVT9uJpuowVEyZtK0Y8XD5M51qtZspmv8cC5EfPnfzM6WzQpxy0RA51fcDx02OM4hBQQG1B_GdIQZxY0TEJCA..%26dur%3D1~KLUv_WMFoCgkiQAtBABjRhgXYN3BxEd1ARlsc9OEJMUDRDMUUOVaolTp9s6U74TFipeOhPTUr1Sjrkp9ot1UFiyEJEWqyhACScdg_slIySmD3tQkgEnOeAvgaDfvEluYAMKb4VRlCLEh2aYofhSVaRgEC_wubt8BdM7UUedH-NZQK9qAnOakwtTkkz3oLR-aJ1cF%26durs%3DvhlyCc%26bdc%3D131%26uidd%3DABXV-5_QgUmu6NDpCAR5Cdrsq3OA2V5jdpd7L-BQ7UKWDJUf%26idl%3DXY3007-b1mUh2_ZHt5ozhj2Bk7EeDcHnRX_2_I1fVlrzRfUms%26testid%3Diavc1%2520%26ict%3DEthernet%26said%3D864524d1-a93d-4bfe-9066-888e87055d57%26auct%3D1%26us_privacy%3D1YNN%26tail%3D1%26r%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=1I1q-5_L'4;gcsr=m;stc=1;chaa=1;sttr=59;prcl=s104.94
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://ep1.adtrafficquality.google/bg/DPVnEqOOr8GEkyz-5oBqyWDy70NS1PVNM5rSU7EcCeQ.js52.04
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74
    https://s0.2mdn.net/sadbundle/6795752907673833826/300x600_24_tha_fp_2045_AS_Program/images/img3.jpg25.81

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2